APA (7th ed.) Citation

L, Z., T, Y., S, Z., D, L., C, F., J, N., . . . A, M. (2025). Targeting myeloid differentiation protein 2 ameliorates rheumatoid arthritis by inhibiting inflammation and ferroptosis via MAPK and NF-κB signaling pathways. Journal of molecular medicine (Berlin, Germany), 103(7), 821. https://doi.org/10.1007/s00109-025-02555-8

Chicago Style (17th ed.) Citation

L, Zhou, et al. "Targeting Myeloid Differentiation Protein 2 Ameliorates Rheumatoid Arthritis by Inhibiting Inflammation and Ferroptosis via MAPK and NF-κB Signaling Pathways." Journal of Molecular Medicine (Berlin, Germany) 103, no. 7 (2025): 821. https://doi.org/10.1007/s00109-025-02555-8.

MLA (9th ed.) Citation

L, Zhou, et al. "Targeting Myeloid Differentiation Protein 2 Ameliorates Rheumatoid Arthritis by Inhibiting Inflammation and Ferroptosis via MAPK and NF-κB Signaling Pathways." Journal of Molecular Medicine (Berlin, Germany), vol. 103, no. 7, 2025, p. 821, https://doi.org/10.1007/s00109-025-02555-8.